NEOGEN CORP Files Q1 2026 10-Q Report
Ticker: NEOG · Form: 10-Q · Filed: 2026-04-09T16:03:42-04:00
Sentiment: neutral
Topics: 10-Q, quarterly-report, financials
TL;DR
NEOGEN CORP dropped its Q1 2026 10-Q. Check financials.
AI Summary
NEOGEN CORP filed its quarterly report (10-Q) on April 9, 2026, for the period ending February 28, 2026. The filing includes various documents related to its financial reporting, such as the iXBRL 10-Q document and exhibits like certifications and a graphic image. NEOGEN CORP is based in Lansing, MI, with its fiscal year ending May 31.
Why It Matters
This filing provides investors and analysts with an update on NEOGEN CORP's financial performance and operational status for the most recent fiscal quarter.
Risk Assessment
Risk Level: low — This is a routine quarterly filing and does not indicate any immediate or unusual risks.
Key Numbers
- 2683903 — iXBRL 10-Q Size (Size of the interactive data filing)
- 11854441 — Complete Submission Text File Size (Size of the full submission text)
Key Players & Entities
- NEOGEN CORP (company) — Filer of the 10-Q report
- 0000711377 (company) — CIK number for NEOGEN CORP
- 2026-02-28 (date) — End of the reporting period
- 2026-04-09 (date) — Filing date of the 10-Q
- LANSING MI (location) — Mailing and business address of NEOGEN CORP
FAQ
What is the period of report for this 10-Q filing?
The period of report is February 28, 2026.
When was this 10-Q filing accepted by the SEC?
The filing was accepted on April 9, 2026.
What is the CIK number for NEOGEN CORP?
The CIK number for NEOGEN CORP is 0000711377.
Where is NEOGEN CORP located?
NEOGEN CORP is located in Lansing, MI.
What is the fiscal year end for NEOGEN CORP?
NEOGEN CORP's fiscal year ends on May 31.
From the Filing
EDGAR Filing Documents for 0001193125-26-149599 This page uses Javascript. Your browser either doesn't support Javascript or you have it turned off. To see this page as it is meant to appear please use a Javascript enabled browser. SEC.gov EDGAR Latest Filings Filings search tools Filing Detail SEC Home » Company Search » Current Page Form 10-Q - Quarterly report [Sections 13 or 15(d)]: SEC Accession No. 0001193125-26-149599 Filing Date 2026-04-09 Accepted 2026-04-09 16:03:42 Documents 64 Period of Report 2026-02-28 Interactive Data Document Format Files Seq Description Document Type Size 1 10-Q neog-20260228.htm iXBRL 10-Q 2683903 2 EX-31.1 neog-ex31_1.htm EX-31.1 15855 3 EX-31.2 neog-ex31_2.htm EX-31.2 15633 4 EX-32 neog-ex32.htm EX-32 12984 5 GRAPHIC img184189947_0.jpg GRAPHIC 646845 Complete submission text file 0001193125-26-149599.txt 11854441 Data Files Seq Description Document Type Size 6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT neog-20260228.xsd EX-101.SCH 1129945 68 EXTRACTED XBRL INSTANCE DOCUMENT neog-20260228_htm.xml XML 2228125 Mailing Address 620 LESHER PLACE LANSING MI 48912 Business Address 620 LESHER PLACE LANSING MI 48912 5173729200 NEOGEN CORP (Filer) CIK : 0000711377 (see all company filings) EIN. : 382367843 | State of Incorp.: MI | Fiscal Year End: 0531 Type: 10-Q | Act: 34 | File No.: 000-17988 | Film No.: 26851558 SIC : 2835 In Vitro & In Vivo Diagnostic Substances (CF Office: 03 Life Sciences)